Skip to main content

Advertisement

SpringerLink
Log in

Phenazines as potential biomarkers of Pseudomonas aeruginosa infections: synthesis regulation, pathogenesis and analytical methods for their detection

  • Feature Article
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Infectious diseases are still a worldwide important problem. This fact has led to the characterization of new biomarkers that would allow an early, fast and reliable diagnostic and targeted therapy. In this context, Pseudomonas aeruginosa can be considered one of the most threatening pathogens since it causes a wide range of infections, mainly in patients that suffer other diseases. Antibiotic treatment is not trivial given the incidence of resistance processes and the fewer new antibiotics that are placed on the market. With this scenario, relevant quorum sensing (QS) molecules that regulate the secretion of virulence factors and biofilm formation can play an important role in diagnostic and therapeutic issues. In this review, we have focused our attention on phenazines, as possible new biomarkers. They are pigmented metabolites that are produced by diverse bacteria, characterized for presenting unique redox properties. Phenazines are involved in virulence, competitive fitness and are an essential component of the bacterial QS system. Here we describe their role in bacterial pathogenesis and we revise phenazine production regulation systems. We also discuss phenazine levels previously reported in bacterial isolates and in clinical samples to evaluate them as putative good candidates to be used as P. aeruginosa infection biomarkers. Moreover we deeply go through all analytical techniques that have been used for their detection and also new approaches are discussed from a critical point.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jefferies JMC, Cooper T, Yam T, Clarke SC. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit – a systematic review of risk factors and environmental sources. J Med Microbiol. 2012;61(Pt 8):1052–61. https://doi.org/10.1099/jmm.0.044818-0.

    Article  CAS  PubMed  Google Scholar 

  2. Williams BJ, Dehnbostel J, Blackwell TS. Pseudomonas aeruginosa: host defence in lung diseases. Respirology (Carlton, Vic). 2010;15(7):1037–56. https://doi.org/10.1111/j.1440-1843.2010.01819.x.

    Article  Google Scholar 

  3. Olejnickova K, Hola V, Ruzicka F. Catheter-related infections caused by Pseudomonas aeruginosa: virulence factors involved and their relationships. Pathog Dis. 2014;72(2):87–94. https://doi.org/10.1111/2049-632X.12188.

    Article  CAS  PubMed  Google Scholar 

  4. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001;183(3):444–52. https://doi.org/10.1086/318075.

    Article  CAS  PubMed  Google Scholar 

  5. Høiby N, Johansen HK, Moser C, Ciofu O. Clinical relevance of Pseudomonas aeruginosa: a master of adaptation and survival strategies. In Pseudomonas model organism, pathogen, cell factory. Weinheim: Wiley-VCH GmbH & Co.; 2008.

    Google Scholar 

  6. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, et al. Genetic adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients is Catalyzed by Hypermutation. J Bacteriol. 2008;190(24):7910–7. https://doi.org/10.1128/jb.01147-08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Boles BR, Thoendel M, Singh PK. Genetic variation in biofilms and the insurance effects of diversity. Microbiology. 2005;151(9):2816–8. https://doi.org/10.1099/mic.0.28224-0.

    Article  CAS  PubMed  Google Scholar 

  8. Boles BR, Singh PK. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A. 2008;105(34):12503–8. https://doi.org/10.1073/pnas.0801499105.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Hoiby N. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology. 2010;156(Pt 4):1108–19. https://doi.org/10.1099/mic.0.033993-0.

    Article  CAS  PubMed  Google Scholar 

  10. Rada B, Leto TL. Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections. Trends Microbiol. 2013;21(2):73–81. https://doi.org/10.1016/j.tim.2012.10.004.

    Article  CAS  PubMed  Google Scholar 

  11. Lau GW, Hassett DJ, Britigan BE. Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol. 2005;13(8):389–97. https://doi.org/10.1016/j.tim.2005.05.011.

    Article  CAS  PubMed  Google Scholar 

  12. Faure E, Kwong K, Nguyen D. Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host? Front Immunol. 2018;9:2416. https://doi.org/10.3389/fimmu.2018.02416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mudau M, Jacobson R, Minenza N, Kuonza L, Morris V, Engelbrecht H, et al. Outbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a south African academic hospital. PLoS One. 2013;8(3):e55985. https://doi.org/10.1371/journal.pone.0055985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Muraki Y, Kitamura M, Maeda Y, Kitahara T, Mori T, Ikeue H, et al. Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. Infection. 2013;41(2):415–23. https://doi.org/10.1007/s15010-013-0440-0.

    Article  CAS  PubMed  Google Scholar 

  15. Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, et al. International nosocomial infection control consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control. 2012;40(5):396–407.

    Article  PubMed  Google Scholar 

  16. Xiao M, Wang Y, Yang QW, Fan X, Brown M, Kong F, et al. Antimicrobial susceptibility of Pseudomonas aeruginosa in China: A review of two multicentre surveillance programmes, and application of revised CLSI susceptibility breakpoints. Int J Antimicrob Agents. 2012;40(5):445–9. https://doi.org/10.1016/j.ijantimicag.2012.07.002.

    Article  CAS  PubMed  Google Scholar 

  17. Marra AR, Camargo LFA, Pignatari ACC, Sukiennik T, Behar PRP, Medeiros EAS, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49(5):1866–71. https://doi.org/10.1128/JCM.00376-11.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Schwarzer C, Fischer H, Machen TE. Chemotaxis and binding of Pseudomonas aeruginosa to scratch-wounded human cystic fibrosis airway epithelial cells. PLoS One. 2016;11(3):e0150109. https://doi.org/10.1371/journal.pone.0150109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H, et al. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun. 1998;66(1):43–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Adamo R, Sokol S, Soong G, Gomez MI, Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol. 2004;30(5):627–34. https://doi.org/10.1165/rcmb.2003-0260OC.

    Article  CAS  PubMed  Google Scholar 

  21. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci U S A. 1997;94(22):12088–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kucharska I, Liang B, Ursini N, Tamm LK. Molecular interactions of lipopolysaccharide with an outer membrane protein from Pseudomonas aeruginosa probed by solution NMR. Biochemistry. 2016;55(36):5061–72. https://doi.org/10.1021/acs.biochem.6b00630.

    Article  CAS  PubMed  Google Scholar 

  23. Pier GB. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol. 2007;297(5):277–95. https://doi.org/10.1016/j.ijmm.2007.03.012.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 2009;7(9):654–65. https://doi.org/10.1038/nrmicro2199.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Winstanley C, Fothergill JL. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett. 2009;290(1):1–9. https://doi.org/10.1111/j.1574-6968.2008.01394.x.

    Article  CAS  PubMed  Google Scholar 

  26. Jakobsen TH, Bjarnsholt T, Jensen PO, Givskov M, Hoiby N. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors. Future Microbiol. 2013;8(7):901–21. https://doi.org/10.2217/fmb.13.57.

    Article  CAS  PubMed  Google Scholar 

  27. Williams P, Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol. 2009;12(2):182–91. https://doi.org/10.1016/j.mib.2009.01.005.

    Article  CAS  PubMed  Google Scholar 

  28. Middleton B, Rodgers HC, Camara M, Knox AJ, Williams P, Hardman A. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbiol Lett. 2002;207(1):1–7. https://doi.org/10.1111/j.1574-6968.2002.tb11019.x.

    Article  CAS  PubMed  Google Scholar 

  29. Collier DN, Anderson L, McKnight SL, Noah TL, Knowles M, Boucher R, et al. A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett. 2002;215(1):41–6. https://doi.org/10.1111/j.1574-6968.2002.tb11367.x.

    Article  CAS  PubMed  Google Scholar 

  30. Morlon-Guyot J, Mere J, Bonhoure A, Beaumelle B. Processing of Pseudomonas aeruginosa exotoxin A is dispensable for cell intoxication. Infect Immun. 2009;77(7):3090–9. https://doi.org/10.1128/iai.01390-08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Jaffar-Bandjee MC, Lazdunski A, Bally M, Carrere J, Chazalette JP, Galabert C. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol. 1995;33(4):924–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hall S, McDermott C, Anoopkumar-Dukie S, McFarland AJ, Forbes A, Perkins AV et al. Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa. Toxins (Basel). 2016;8(8). doi:https://doi.org/10.3390/toxins8080236.

  33. Bell SC, De Boeck K, Amaral MD. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol Ther. 2015;145:19–34. https://doi.org/10.1016/j.pharmthera.2014.06.005.

    Article  CAS  PubMed  Google Scholar 

  34. Mossine VV, Waters JK, Chance DL, Mawhinney TP. Transient Proteotoxicity of bacterial virulence factor Pyocyanin in renal tubular epithelial cells induces ER-related Vacuolation and can be efficiently modulated by Iron chelators. Toxicol Sci. 2016;154(2):403–15. https://doi.org/10.1093/toxsci/kfw174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Muller M, Li Z, Maitz PK. Pseudomonas pyocyanin inhibits wound repair by inducing premature cellular senescence: role for p38 mitogen-activated protein kinase. Burns. 2009;35(4):500–8. https://doi.org/10.1016/j.burns.2008.11.010.

    Article  PubMed  Google Scholar 

  36. Lau GW, Hassett DJ, Ran H, Kong F. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med. 2004;10(12):599–606. https://doi.org/10.1016/j.molmed.2004.10.002.

    Article  CAS  PubMed  Google Scholar 

  37. Costa KC, Bergkessel M, Saunders S, Korlach J, Newman DK. Enzymatic degradation of Phenazines can generate energy and protect sensitive organisms from toxicity. mBio. 2015;6(6):e01520–15. https://doi.org/10.1128/mBio.01520-15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wu HJ, Wang AH, Jennings MP. Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol. 2008;12(1):93–101. https://doi.org/10.1016/j.cbpa.2008.01.023.

    Article  CAS  PubMed  Google Scholar 

  39. Mavrodi DV, Blankenfeldt W, Thomashow LS. Phenazine compounds in fluorescent Pseudomonas spp. biosynthesis and regulation. Annu. Rev. Phytopathol. 2006;44:417–45. https://doi.org/10.1146/annurev.phyto.44.013106.145710.

    Article  CAS  Google Scholar 

  40. Ramos I, Dietrich LE, Price-Whelan A, Newman DK. Phenazines affect biofilm formation by Pseudomonas aeruginosa in similar ways at various scales. Res Microbiol. 2010;161(3):187–91. https://doi.org/10.1016/j.resmic.2010.01.003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Du X, Li Y, Zhou Q, Xu Y. Regulation of gene expression in Pseudomonas aeruginosa M18 by phenazine-1-carboxylic acid. Appl Microbiol Biotechnol. 2015;99(2):813–25. https://doi.org/10.1007/s00253-014-6101-0.

    Article  CAS  PubMed  Google Scholar 

  42. Dietrich LE, Teal TK, Price-Whelan A, Newman DK. Redox-active antibiotics control gene expression and community behavior in divergent bacteria. Science. 2008;321(5893):1203–6. https://doi.org/10.1126/science.1160619.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Dowling DN, O'Gara F. Metabolites of Pseudomonas involved in the biocontrol of plant disease. Trends Biotechnol. 1994;12(4):133–41. https://doi.org/10.1016/0167-7799(94)90091-4.

    Article  CAS  Google Scholar 

  44. Laursen JB, Nielsen J. Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem Rev. 2004;104(3):1663–86. https://doi.org/10.1021/cr020473j.

    Article  CAS  PubMed  Google Scholar 

  45. Pierson LS III, Pierson EA. Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. Appl Microbiol Biotechnol. 2010;86(6):1659–70. https://doi.org/10.1007/s00253-010-2509-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Fordos M. Recherches sur les matieres colorantes des suppurations bleues, pyocyanine et pyoxanthose. CR Hebd Seances Acad Sci. 1863;56:1128–31.

    Google Scholar 

  47. Reyes EA, Bale MJ, Cannon WH, Matsen JM. Identification of Pseudomonas aeruginosa by pyocyanin production on tech agar. J Clin Microbiol. 1981;13(3):456–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988;56(9):2515–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Penesyan A, Kumar SS, Kamath K, Shathili AM, Venkatakrishnan V, Krisp C, et al. Genetically and phenotypically distinct Pseudomonas aeruginosa cystic fibrosis isolates share a Core proteomic signature. PLoS One. 2015;10(10):e0138527. https://doi.org/10.1371/journal.pone.0138527.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol. 1999;104(1):72–8.

    Article  CAS  PubMed  Google Scholar 

  51. Moura-Alves P, Fae K, Houthuys E, Dorhoi A, Kreuchwig A, Furkert J, et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature. 2014;512(7515):387–92. https://doi.org/10.1038/nature13684.

    Article  CAS  PubMed  Google Scholar 

  52. Dietrich LE, Price-Whelan A, Petersen A, Whiteley M, Newman DK. The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa. Mol Microbiol. 2006;61(5):1308–21. https://doi.org/10.1111/j.1365-2958.2006.05306.x.

    Article  CAS  PubMed  Google Scholar 

  53. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, Taylor GW, et al. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol. 2002;168(4):1861–8. https://doi.org/10.4049/jimmunol.168.4.1861.

    Article  CAS  PubMed  Google Scholar 

  54. Allen L, Dockrell DH, Pattery T, Lee DG, Cornelis P, Hellewell PG, et al. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol. 2005;174(6):3643–9. https://doi.org/10.4049/jimmunol.174.6.3643.

    Article  CAS  PubMed  Google Scholar 

  55. Rada B, Leto TL. Redox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyanin. Immunol Res. 2009;43(1–3):198–209. https://doi.org/10.1007/s12026-008-8071-8.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Liu GY, Nizet V. Color me bad: microbial pigments as virulence factors. Trends Microbiol. 2009;17(9):406–13. https://doi.org/10.1016/j.tim.2009.06.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Kanthakumar K, Taylor GW, Cundell DR, Dowling RB, Johnson M, Cole PJ, et al. The effect of bacterial toxins on levels of intracellular adenosine nucleotides and human ciliary beat frequency. Pulm Pharmacol. 1996;9(4):223–30. https://doi.org/10.1006/pulp.1996.0028.

    Article  CAS  PubMed  Google Scholar 

  58. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun. 2004;72(7):4275–8. https://doi.org/10.1128/IAI.72.7.4275-4278.2004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Shellito J, Nelson S, Sorensen RU. Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages. Infect Immun. 1992;60(9):3913–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Kamath JM, Britigan BE, Cox CD, Shasby DM. Pyocyanin from Pseudomonas aeruginosa inhibits prostacyclin release from endothelial cells. Infect Immun. 1995;63(12):4921–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Muller M, Sorrell TC. Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun. 1992;60(6):2536–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Muller M, Sztelma K, Sorrell TC. Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin. Ann N Y Acad Sci. 1994;744:320–2. https://doi.org/10.1111/j.1749-6632.1994.tb52752.x.

    Article  CAS  PubMed  Google Scholar 

  63. Muller M, Sorrell TC. Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun. 1997;65(6):2483–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Britigan BE, Railsback MA, Cox CD. The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. Infect Immun. 1999;67(3):1207–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Denning GM, Railsback MA, Rasmussen GT, Cox CD, Britigan BE. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am J Phys. 1998;274(6 Pt 1):L893–900. https://doi.org/10.1152/ajplung.1998.274.6.L893.

    Article  CAS  Google Scholar 

  66. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, Britigan BE. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun. 1998;66(12):5777–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Denning GM, Iyer SS, Reszka KJ, O'Malley Y, Rasmussen GT, Britigan BE. Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa, alters expression of immunomodulatory proteins by human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;285(3):L584–92. https://doi.org/10.1152/ajplung.00086.2003.

    Article  CAS  PubMed  Google Scholar 

  68. Look DC, Stoll LL, Romig SA, Humlicek A, Britigan BE, Denning GM. Pyocyanin and its precursor phenazine-1-carboxylic acid increase IL-8 and intercellular adhesion molecule-1 expression in human airway epithelial cells by oxidant-dependent mechanisms. J Immunol. 2005;175(6):4017–23. https://doi.org/10.4049/jimmunol.175.6.4017.

    Article  CAS  PubMed  Google Scholar 

  69. Caldwell CC, Chen Y, Goetzmann HS, Hao Y, Borchers MT, Hassett DJ, et al. Pseudomonas aeruginosa exotoxin Pyocyanin causes cystic fibrosis airway pathogenesis. Am J Pathol. 2009;175(6):2473–88. https://doi.org/10.2353/ajpath.2009.090166.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Mavrodi DV, Parejko JA, Mavrodi OV, Kwak YS, Weller DM, Blankenfeldt W, et al. Recent insights into the diversity, frequency and ecological roles of phenazines in fluorescent Pseudomonas spp. Environ Microbiol. 2013;15(3):675–86. https://doi.org/10.1111/j.1462-2920.2012.02846.x.

    Article  CAS  PubMed  Google Scholar 

  71. Haas D, Defago G. Biological control of soil-borne pathogens by fluorescent pseudomonads. Nat Rev Microbiol. 2005;3(4):307–19. https://doi.org/10.1038/nrmicro1129.

    Article  CAS  PubMed  Google Scholar 

  72. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol. 2012;47(6):738–45. https://doi.org/10.1165/rcmb.2012-0088OC.

    Article  CAS  PubMed  Google Scholar 

  73. Cui Q, Lv H, Qi Z, Jiang B, Xiao B, Liu L, et al. Cross-regulation between the phz1 and phz2 operons maintain a balanced level of Phenazine biosynthesis in Pseudomonas aeruginosa PAO1. PLoS One. 2016;11(1):e0144447. https://doi.org/10.1371/journal.pone.0144447.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Mavrodi DV, Peever TL, Mavrodi OV, Parejko JA, Raaijmakers JM, Lemanceau P, et al. Diversity and evolution of the phenazine biosynthesis pathway. Appl Environ Microbiol. 2010;76(3):866–79. https://doi.org/10.1128/aem.02009-09.

    Article  CAS  PubMed  Google Scholar 

  75. Sakhtah HP-WA, Dietrich LEP. Regulation of Phenazyne biosynthesis. In: Chincholkar SaT L, editor. Microbial Phenazines. Heidelberg: Springer-Verlag; 2013. p. 19–42.

    Chapter  Google Scholar 

  76. Dubern JF, Diggle SP. Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol BioSyst. 2008;4(9):882–8. https://doi.org/10.1039/b803796p.

    Article  CAS  PubMed  Google Scholar 

  77. Subramaniyan S, Divyasree S, Sandhia GS. Phytochemicals as effective quorum quenchers against bacterial communication. Recent Pat Biotechnol. 2016;10(2):153–66.

    Article  CAS  PubMed  Google Scholar 

  78. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Deziel E, Smith EE, et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol. 2007;64(2):512–33. https://doi.org/10.1111/j.1365-2958.2007.05678.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW, et al. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros. 2009;8(1):66–70. https://doi.org/10.1016/j.jcf.2008.09.006.

    Article  CAS  PubMed  Google Scholar 

  80. Fothergill J, Panagea S, Hart C, Walshaw M, Pitt T, Winstanley C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol. 2007;7(1):45. https://doi.org/10.1186/1471-2180-7-45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Firoved AM, Boucher JC, Deretic V. Global genomic analysis of AlgU (sigma(E))-dependent promoters (sigmulon) in Pseudomonas aeruginosa and implications for inflammatory processes in cystic fibrosis. J Bacteriol. 2002;184(4):1057–64. https://doi.org/10.1128/jb.184.4.1057-1064.2002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Ryall B, Carrara M, Zlosnik JE, Behrends V, Lee X, Wong Z, et al. The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation. PLoS One. 2014;9(5):e96166. https://doi.org/10.1371/journal.pone.0096166.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Damron FH, Barbier M, McKenney ES, Schurr MJ, Goldberg JB. Genes required for and effects of alginate overproduction induced by growth of Pseudomonas aeruginosa on Pseudomonas isolation agar supplemented with ammonium metavanadate. J Bacteriol. 2013;195(18):4020–36. https://doi.org/10.1128/JB.00534-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Resp Crit Care. 2011;183(12):1674–9. https://doi.org/10.1164/rccm.201009-1430OC.

    Article  Google Scholar 

  85. Bohn YS, Brandes G, Rakhimova E, Horatzek S, Salunkhe P, Munder A, et al. Multiple roles of Pseudomonas aeruginosa TBCF10839 PilY1 in motility, transport and infection. Mol Microbiol. 2009;71(3):730–47. https://doi.org/10.1111/j.1365-2958.2008.06559.x.

    Article  CAS  PubMed  Google Scholar 

  86. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D’Argenio DA, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A. 2006;103(22):8487–92. https://doi.org/10.1073/pnas.0602138103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Cabeen MT. Stationary phase-specific virulence factor overproduction by a lasR mutant of Pseudomonas aeruginosa. PLoS One. 2014;9(2):e88743. https://doi.org/10.1371/journal.pone.0088743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Aaron SD, Kottachchi D, Ferris WJ, Vandemheen KL, St Denis ML, Plouffe A, et al. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis. Eur Respir J. 2004;24(4):631–7. https://doi.org/10.1183/09031936.04.00049104.

    Article  CAS  PubMed  Google Scholar 

  89. Goss CH, Burns JL. Exacerbations in cystic fibrosis · 1: epidemiology and pathogenesis. Thorax. 2007;62(4):360–7. https://doi.org/10.1136/thx.2006.060889.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Suzuki S, Mano Y, Fujitani K, Furuya N. Effects of long- term, low-dose macrolide treatment on Pseudomonas aeruginosa PAO1 virulence factors in vitro. Arch Clin Microbiol. 2017;8(4):50. https://doi.org/10.4172/1989-8436.100050.

    Article  Google Scholar 

  91. El-Fouly MZ, Sharaf AM, Shahin AAM, El-Bialy HA, Omara AMA. Biosynthesis of pyocyanin pigment by Pseudomonas aeruginosa. J Radiat Res Appl Sci. 2015;8(1):36–48. https://doi.org/10.1016/j.jrras.2014.10.007.

    Article  CAS  Google Scholar 

  92. Silva LV, Galdino AC, Nunes AP, Dos Santos KR, Moreira BM, Cacci LC, et al. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa. Int J Med Microbiol. 2014;304:990–1000. https://doi.org/10.1016/j.ijmm.2014.07.001.

    Article  PubMed  Google Scholar 

  93. Tielen P, Narten M, Rosin N, Biegler I, Haddad I, Hogardt M, et al. Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int J Med Microbiol. 2011;301(4):282–92. https://doi.org/10.1016/j.ijmm.2010.10.005.

    Article  CAS  PubMed  Google Scholar 

  94. Cigana C, Melotti P, Baldan R, Pedretti E, Pintani E, Iansa P, et al. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. BMC Microbiol. 2016;16(1):142. https://doi.org/10.1186/s12866-016-0760-1.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Khadim MM, Al Marjani MF. Pyocyanin and biofilm formation in Pseudomonas aeruginosa isolated from burn infections in Baghdad. Iraq Jordan J Biol Sci. 2019;12:31–5.

    CAS  Google Scholar 

  96. Wilson R, Pitt T, Taylor G, Watson D, MacDermot J, Sykes D, et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987;79(1):221–9. https://doi.org/10.1172/jci112787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Reimer Å. Concentrations of the Pseudomonas aeruginosa toxin Pyocyanin in human ear secretions. Acta Otolaryngol. 2000;120(543):86–8. https://doi.org/10.1080/000164800454062.

    Article  Google Scholar 

  98. Retraction: Phenazine Content in the Cystic Fibrosis Respiratory Tract Negatively Correlates with Lung Function and Microbial Complexity. Am. J. Respir. Cell Mol Biol 2019;60(1):134-. doi:https://doi.org/10.1165/rcmb.601retraction.

  99. Reszka KJ, O'Malley Y, McCormick ML, Denning GM, Britigan BE. Oxidation of pyocyanin, a cytotoxic product from Pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide. Free Radical Bio Med. 2004;36(11):1448–59. https://doi.org/10.1016/j.freeradbiomed.2004.03.011.

    Article  CAS  Google Scholar 

  100. Cheluvappa R. Standardized chemical synthesis of Pseudomonas aeruginosa pyocyanin. MethodsX. 2014;1:67–73. https://doi.org/10.1016/j.mex.2014.07.001.

    Article  PubMed  PubMed Central  Google Scholar 

  101. El-Mowafy SA, Abd El Galil KH, El-Messery SM, Shaaban MI. Aspirin is an efficient inhibitor of quorum sensing, virulence and toxins in Pseudomonas aeruginosa. Microb Pathog. 2014;74(0):25–32. https://doi.org/10.1016/j.micpath.2014.07.008.

    Article  CAS  PubMed  Google Scholar 

  102. Essar DW, Eberly L, Hadero A, Crawford IP. Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol. 1991;172(2):884–900. https://doi.org/10.1128/jb.172.2.884-900.1990.

    Article  Google Scholar 

  103. Kurachi M. Studies on the biosynthesis of Pyocyanine (II): isolation and determination of Pyocyanine. Bull Inst Chem Res. 1958;36(6):174–87.

    Google Scholar 

  104. Wang Y, Wilks JC, Danhorn T, Ramos I, Croal L, Newman DK. Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition. J Bacteriol. 2011;193(14):3606–17. https://doi.org/10.1128/jb.00396-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G, Thomashow LS. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J Bacteriol. 2001;183(21):6454–65. https://doi.org/10.1128/jb.183.21.6454-6465.2001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Watson D, MacDermot J, Wilson R, Cole PJ, Taylor GW. Purification and structural analysis of pyocyanin and 1-hydroxyphenazine. Eur J Biochem. 1986;159(2):309–13.

    Article  CAS  PubMed  Google Scholar 

  107. Sharp D, Gladstone P, Smith RB, Forsythe S, Davis J. Approaching intelligent infection diagnostics: carbon fibre sensor for electrochemical pyocyanin detection. Bioelectrochemistry. 2010;77(2):114–9. https://doi.org/10.1016/j.bioelechem.2009.07.008.

    Article  CAS  PubMed  Google Scholar 

  108. Webster TA, Sismaet HJ, Goluch ED. Amperometric detection of pyocyanin in nanofluidic channels. Nano LIFE. 2013;03(01):1340011. https://doi.org/10.1142/S1793984413400114.

    Article  CAS  Google Scholar 

  109. Webster TA, Goluch ED. Electrochemical detection of pyocyanin in nanochannels with integrated palladium hydride reference electrodes. Lab Chip. 2012;12(24):5195–201. https://doi.org/10.1039/C2LC40650K.

    Article  CAS  PubMed  Google Scholar 

  110. Alatraktchi FA, Johansen HK, Molin S, Svendsen WE. Electrochemical sensing of biomarker for diagnostics of bacteria-specific infections. Nanomedicine (Lond). 2016;11(16):2185–95. https://doi.org/10.2217/nnm-2016-0155.

    Article  CAS  Google Scholar 

  111. Alatraktchi FA, Andersen SB, Johansen HK, Molin S, Svendsen WE. Fast Selective Detection of Pyocyanin Using Cyclic Voltammetry. Sensors (Basel). 2016;16(3). doi:https://doi.org/10.3390/s16030408.

  112. Webster TA, Sismaet HJ, Conte JL, Chan IJ, Goluch ED. Electrochemical detection of Pseudomonas aeruginosa in human fluid samples via pyocyanin. Biosens Bioelectron. 2014;60(0):265–70. https://doi.org/10.1016/j.bios.2014.04.028.

    Article  CAS  PubMed  Google Scholar 

  113. Sismaet HJ, Banerjee A, McNish S, Choi Y, Torralba M, Lucas S, et al. Electrochemical detection of Pseudomonas in wound exudate samples from patients with chronic wounds. Wound Repair Regen. 2016;24(2):366–72. https://doi.org/10.1111/wrr.12414.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Sismaet HJ, Pinto AJ, Goluch ED. Electrochemical sensors for identifying pyocyanin production in clinical Pseudomonas aeruginosa isolates. Biosens Bioelectron. 2017;97:65–9. https://doi.org/10.1016/j.bios.2017.05.042.

    Article  CAS  PubMed  Google Scholar 

  115. Yang Y, Yu YY, Wang YZ, Zhang CL, Wang JX, Fang Z, et al. Amplification of electrochemical signal by a whole-cell redox reactivation module for ultrasensitive detection of pyocyanin. Biosens Bioelectron. 2017;98:338–44. https://doi.org/10.1016/j.bios.2017.07.008.

    Article  CAS  PubMed  Google Scholar 

  116. Alatraktchi FA, Noori JS, Tanev GP, Mortensen J, Dimaki M, Johansen HK, et al. Paper-based sensors for rapid detection of virulence factor produced by Pseudomonas aeruginosa. PLoS One. 2018;13(3):e0194157. https://doi.org/10.1371/journal.pone.0194157.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Elkhawaga AA, Khalifa MM, El-Badawy O, Hassan MA, El-Said WA. Rapid and highly sensitive detection of pyocyanin biomarker in different Pseudomonas aeruginosa infections using gold nanoparticles modified sensor. PLoS One. 2019;14(7):e0216438. https://doi.org/10.1371/journal.pone.0216438.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Rusciano G, Capriglione P, Pesce G, Abete P, Carnovale V, Sasso A. Raman spectroscopy as a new tool for early detection of bacteria in patients with cystic fibrosis. Laser Phys Lett. 2013;10(7):075603. https://doi.org/10.1088/1612-2011/10/7/075603.

    Article  CAS  Google Scholar 

  119. Wu X, Chen J, Li X, Zhao Y, Zughaier SM. Culture-free diagnostics of Pseudomonas aeruginosa infection by silver nanorod array based SERS from clinical sputum samples. Nanomedicine. 2014. https://doi.org/10.1016/j.nano.2014.04.010.

  120. Polisetti S, Baig NF, Morales-Soto N, Shrout JD, Bohn PW. Spatial mapping of Pyocyanin in Pseudomonas aeruginosa bacterial communities using surface enhanced Raman scattering. Appl Spectrosc. 2017;71(2):215–23. https://doi.org/10.1177/0003702816654167.

    Article  CAS  PubMed  Google Scholar 

  121. Jia F, Barber E, Turasan H, Seo S, Dai R, Liu L, et al. Detection of Pyocyanin using a new biodegradable SERS biosensor fabricated using gold coated Zein nanostructures further decorated with gold nanoparticles. J Agric Food Chem. 2019;67(16):4603–10. https://doi.org/10.1021/acs.jafc.8b07317.

    Article  CAS  PubMed  Google Scholar 

  122. Pastells C, Pascual N, Sanchez-Baeza F, Marco MP. Immunochemical determination of Pyocyanin and 1-Hydroxyphenazine as potential biomarkers of Pseudomonas aeruginosa infections. Anal Chem. 2016;88(3):1631–8. https://doi.org/10.1021/acs.analchem.5b03490.

    Article  CAS  PubMed  Google Scholar 

  123. Karatuna O, Yagci A. Analysis of quorum sensing-dependent virulence factor production and its relationship with antimicrobial susceptibility in Pseudomonas aeruginosa respiratory isolates. Clin Microbiol Infect. 2010;16(12):1770–5. https://doi.org/10.1111/j.1469-0691.2010.03177.x.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work has been funded by the Spanish government through the project QS4CF (RTI2018-096278-B-C21), by Fundació La Marató de TV3 (201825-30-31) and by the program Marie Sklodowska Research Fellowship through the project New Diagnostics for Infectious Diseases (ND4ID, 675412-ND4ID-H2020-MSCA-ITN-2015). The Nb4D group (formerly Applied Molecular Receptors group, AMRg) is a consolidated research group (Grup de Recerca) of the Generalitat de Catalunya and has support from the Departament d’Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya (expedient: 2014 SGR 1484). CIBER-BBN is an initiative funded by the Spanish National Plan for Scientific and Technical Research and Innovation 2013-2016, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions are financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. The ICTS “NANBIOSIS”, and particularly the Custom Antibody Service (CAbS, IQAC-CSIC, CIBER-BBN), is acknowledged for the assistance and support related to some immunoreagents mentioned in this work.

Author information

Authors and Affiliations

  1. Nanobiotechnology for Diagnostics (Nb4D), Institute of Advanced Chemistry of Catalonia, IQAC-CSIC, Jordi Girona, 18-26, 08034, Barcelona, Spain

    Lluïsa Vilaplana & M.-Pilar Marco

  2. CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Jordi Girona, 18-26, 08034, Barcelona, Spain

    Lluïsa Vilaplana & M.-Pilar Marco

Authors
  1. Lluïsa Vilaplana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.-Pilar Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lluïsa Vilaplana.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Published in the topical collection featuring Female Role Models in Analytical Chemistry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vilaplana, L., Marco, MP. Phenazines as potential biomarkers of Pseudomonas aeruginosa infections: synthesis regulation, pathogenesis and analytical methods for their detection. Anal Bioanal Chem 412, 5897–5912 (2020). https://doi.org/10.1007/s00216-020-02696-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-020-02696-4

Keywords

Search

Navigation